Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
The impact on Phase III trials is particularly significant, as these later-stage studies involve larger, committed patient populations and represent years of investment
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
